Literature DB >> 10580325

Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization.

B Acunaş1, I Rozanes.   

Abstract

This article presents a review of the literature regarding the use of transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). There have been two different approaches to the treatment: (a) percutaneous tumor ablation methods which can be divided into injectable and thermal methods; percutaneous ethanol injection (PEI) is the most widely used method, and (b) TACE. PEI is the treatment of choice for single HCCs smaller or equal to 3 cm in size. For patients with large HCCs combined TACE and PEI is probably the most effective nonsurgical treatment. In the presence of multiple HCC nodules, TACE remains the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580325     DOI: 10.1016/s0720-048x(99)00117-5

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  14 in total

1.  Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone.

Authors:  Yan-Bin Wang; Min-Hua Chen; Kun Yan; Wei Yang; Ying Dai; Shan-Shan Yin
Journal:  Qual Life Res       Date:  2006-11-17       Impact factor: 4.147

2.  Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma.

Authors:  Ying-Wen Su; Yu-Wen Huang; Sheng-Hsuan Chen; Chin-Yuan Tzen
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

3.  Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.

Authors:  Arne Dettmer; Timm-D Kirchhoff; Michael Gebel; Lars Zender; Nisar-P Malek; Bernhard Panning; Ajay Chavan; Herbert Rosenthal; Stefan Kubicka; Susanne Krusche; Sonja Merkesdal; Michael Galanski; Michael-P Manns; Joerg-S Bleck
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.

Authors:  Zhi-Jian Yu; Jia-Wei Yu; Wei Cai; Hong-Xin Yuan; Xiao-Yan Li; Ye Yuan; Jian-Ping Chen; Xiao-Yin Wu; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 5.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.

Authors:  Li-Wu Lin; Xue-Ying Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue; Xiao-Dong Lin; Li-Yun Yu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

7.  Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

Authors:  Xiao-Feng Liao; Ji-Lin Yi; Xing-Rui Li; Wei Deng; Zhi-Fang Yang; Geng Tian
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato
Journal:  Radiat Med       Date:  2008-02-27

9.  Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats.

Authors:  Han-Ping Wu; Gan-Sheng Feng; Hui-Min Liang; Chuan-Sheng Zheng; Xin Li
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

10.  Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.

Authors:  Jun Qian; Jochen Truebenbach; Florian Graepler; Philippe Pereira; Peter Huppert; Thomas Eul; Gundula Wiemann; Claus Claussen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.